IVERIC BIO INC's ticker is ISEE and the CUSIP is 46583P102. A total of 176 filers reported holding IVERIC BIO INC in Q4 2021. The put-call ratio across all filers is 0.12 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $2,615,992 | +63.1% | 66,497 | +0.9% | 0.02% | +45.5% |
| Q1 2023 | $1,603,688 | +17.7% | 65,914 | +3.6% | 0.01% | +10.0% |
| Q4 2022 | $1,362,789 | +35.1% | 63,652 | +13.1% | 0.01% | +42.9% |
| Q3 2022 | $1,009,000 | +91.8% | 56,262 | +2.9% | 0.01% | +75.0% |
| Q2 2022 | $526,000 | -45.3% | 54,688 | -4.3% | 0.00% | -20.0% |
| Q1 2022 | $961,000 | -6.0% | 57,119 | -6.6% | 0.01% | 0.0% |
| Q4 2021 | $1,022,000 | +10.1% | 61,140 | +7.0% | 0.01% | 0.0% |
| Q3 2021 | $928,000 | +190.0% | 57,128 | +12.6% | 0.01% | +400.0% |
| Q2 2021 | $320,000 | +10.7% | 50,752 | +8.4% | 0.00% | 0.0% |
| Q1 2021 | $289,000 | -10.5% | 46,821 | +0.3% | 0.00% | 0.0% |
| Q4 2020 | $323,000 | +19.2% | 46,697 | -2.8% | 0.00% | 0.0% |
| Q3 2020 | $271,000 | +92.2% | 48,037 | +74.1% | 0.00% | 0.0% |
| Q2 2020 | $141,000 | – | 27,586 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 1,729,041 | $10,685,000 | 4.26% |
| Soleus Capital Management, L.P. | 3,380,979 | $20,894,000 | 3.76% |
| ACUTA CAPITAL PARTNERS, LLC | 1,579,093 | $9,759,000 | 3.52% |
| Stonepine Capital Management, LLC | 875,180 | $5,409,000 | 2.92% |
| Samsara BioCapital, LLC | 2,372,476 | $14,664,000 | 2.70% |
| Ghost Tree Capital, LLC | 1,125,000 | $6,953,000 | 1.63% |
| Octagon Capital Advisors LP | 680,036 | $4,203,000 | 1.58% |
| Altium Capital Management LP | 902,633 | $5,578,000 | 1.55% |
| Vivo Capital, LLC | 5,966,527 | $36,873,000 | 1.30% |
| FRAZIER MANAGEMENT LLC | 2,544,500 | $15,725,000 | 1.26% |